Skip to main content
Fig. 1 | Journal for ImmunoTherapy of Cancer

Fig. 1

From: Paired whole exome and transcriptome analyses for the Immunogenomic changes during concurrent chemoradiotherapy in esophageal squamous cell carcinoma

Fig. 1

Study flow and CONSORT diagram of the study population. a The first endoscopic sample was obtained at the time of diagnosis. The second sample was acquired at 2 to 3 weeks after initiation of concurrent chemoradiation therapy. b, Samples were acquired from 40 patients with signed informed consent and prepared for genomic analyses. Twenty-nine patients were available for the paired whole-exome sequencing (WES), and 23 patients were available for the paired whole-transcriptome sequencing (WTS). A total of 25 patients underwent curative surgery. Abbreviations: SCC, squamous cell carcinoma; QC, quality control

Back to article page